
CAS 1042224-63-4
:Formula:C17H19N5
InChI:InChI=1S/C17H19N5/c1-2-11-22-15(12-19-17(22)6-1)14-4-3-5-16(21-14)20-13-7-9-18-10-8-13/h1-6,11-13,18H,7-10H2,(H,20,21)
InChI key:HUYUPQNBDBTPQQ-UHFFFAOYSA-N
SMILES:C1CNCCC1NC2=CC=CC(=N2)C3=CN=C4N3C=CC=C4
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
6-(Imidazo[1,2-a]pyridin-3-yl)-N-(piperidin-4-yl)pyridin-2-amine
CAS:Formula:C17H19N5Purity:99%Molecular weight:293.3663IRAK inhibitor 1
CAS:IRAK inhibitor 1 is an effective IRAK-4 inhibitor (IC50: 216 nM), is poorly active against JNK-1 (IC50: 3.801 μM) and JNK-2 (IC50>10 μM).Formula:C17H19N5Purity:97.5% - 99.99%Color and Shape:SolidMolecular weight:293.3663Ref: TM-T5094
1mg89.00€2mg118.00€1mL*10mM (DMSO)128.00€5mg191.00€10mg267.00€25mg447.00€50mg650.00€100mg888.00€6-(Imidazo[1,2-a]pyridin-3-yl)-N-(piperidin-4-yl)pyridin-2-amine
CAS:6-(Imidazo[1,2-a]pyridin-3-yl)-N-(piperidin-4-yl)pyridin-2-amineFormula:C17H19N5Purity:99%Molecular weight:293.37IRAK inhibitor 1
CAS:IRAK inhibitor 1 is a protein kinase inhibitor that blocks the activation of IRAK, which is a kinase. This inhibition leads to the suppression of cancer-related genes and the normalization of protein synthesis. This drug has been shown to be effective in cancer therapy and may also have potential as an adjuvant in other treatments such as chemotherapy.Formula:C17H19N5Purity:Min. 95%Molecular weight:293.37 g/mol




